Physician profile
Khaled Chan
NPI 1255376414
$919.43
in general payments reported to CMS, 2019-2025
18 companies · $584 in 2025
The $584 reported for 2025 was more than what 76% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $72.40 · 2022: $72.93 · 2023: $44.89 · 2024: $146 · 2025: $584.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $774.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $774.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $278.23 | 2023-2025 | Nucala, Arexvy, Shingrix |
| Avadel Cns Pharmaceuticals, LLC | $118.29 | 2025 | Lumryz |
| Viatris Specialty LLC | $95.56 | 2025 | Yupelri |
| Astrazeneca Pharmaceuticals LP | $76.47 | 2024 | Breztri, Airsupra |
| Amgen INC. | $44.99 | 2019 | |
| Madrigal Pharmaceuticals | $37.62 | 2025 | Rezdiffra |
| Neurocrine Biosciences, INC. | $35.65 | 2022 | |
| Ucb, INC. | $35.29 | 2024 | Briviact |
| Lilly USA, LLC | $34.30 | 2019-2025 | Jardiance |
| Axsome Therapeutics, INC. | $27.83 | 2023 | Sunosi |
| Novartis Pharmaceuticals Corporation | $25.90 | 2025 | |
| Regeneron Healthcare Solutions, INC. | $24.95 | 2025 | Dupixent |
| Urovant Sciences INC | $23.13 | 2022 | |
| Inspire Medical Systems, INC. | $18.78 | 2025 | Inspire |
| Exact Sciences Corporation | $14.56 | 2025 | Cologuard Collection Kit |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $14.15 | 2022 | |
| Astellas Pharma US INC | $13.73 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Khaled Chan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.